This online event focused on how Innovative Medicines Initiative (IMI) projects are delivering results to advance the development and uptake of Ebola vaccines.
The project looked for compounds that stop the virus's spike protein from binding with the ACE2 receptor which is found on human cells and is the virus's main route of attack.
The short brochure describes recent IMI project results in fields such as cancer, antimicrobial resistance, COVID-19 and more.
IHI call 1 was a single-stage call with topics on cancer, neurodegenerative diseases, and health data.
Scientists from IMI’s iPiE and PREMIER projects used ePiE to predict levels of ibuprofen in four major European river basins.
The IHI Governing Board has formally approved the Strategic Research and Innovation Agenda (SRIA), which will guide IHI’s scientific priorities in the years to come.
IMI has had ‘big data’ projects since its creation. What’s more, the projects are putting ‘big data’ principles into practice to advance research in the fields of cardiovascular disease...
IHI is funded jointly by the EU and by industry associations representing Europe’s life science industries.